The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Interleukin-2 (IL-2) Market Research Report 2024
Synopsis
The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.
The global Human Interleukin-2 (IL-2) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Interleukin-2 (IL-2) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Interleukin-2 (IL-2) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Interleukin-2 (IL-2) include Roche, BMS, Schering-Plough, AbbVie Inc, Alkermes Plc, APT Therapeutics, Mabtech Limited, Philogen and Sinopharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Interleukin-2 (IL-2), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Interleukin-2 (IL-2).
Report Scope
The Human Interleukin-2 (IL-2) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Interleukin-2 (IL-2) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Interleukin-2 (IL-2) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
BMS
Schering-Plough
AbbVie Inc
Alkermes Plc
APT Therapeutics
Mabtech Limited
Philogen
Sinopharm
Jiangsu Jinsili Pharmaceutical
Shenyang Sansheng Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shandong Quangang Pharmaceutical
Shanghai Huaxin Biological high-tech
Beijing Yuance Pharmaceutical
Beijing Sihuan Biological Pharmaceutical
Beijing Sanyuan Gene Pharmaceutical
Shenzhen Kexing Biological Engineering
Shanghai Sanwei Biotechnology
Xiamen Tebao Biological Engineering
Chengdu huashen Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical
Segment by Type
50000 U
100000 U
200000 U
500000 U
1 Million U
2 Million U
Segment by Application
Recombinant Interferon
Recombinant Interleukin
Natural Biological Products
Poison Immune
Gene Therapy
Monoclonal Antibody
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Interleukin-2 (IL-2) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Interleukin-2 (IL-2) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.
The global Human Interleukin-2 (IL-2) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Interleukin-2 (IL-2) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Interleukin-2 (IL-2) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Interleukin-2 (IL-2) include Roche, BMS, Schering-Plough, AbbVie Inc, Alkermes Plc, APT Therapeutics, Mabtech Limited, Philogen and Sinopharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Interleukin-2 (IL-2), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Interleukin-2 (IL-2).
Report Scope
The Human Interleukin-2 (IL-2) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Interleukin-2 (IL-2) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Interleukin-2 (IL-2) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
BMS
Schering-Plough
AbbVie Inc
Alkermes Plc
APT Therapeutics
Mabtech Limited
Philogen
Sinopharm
Jiangsu Jinsili Pharmaceutical
Shenyang Sansheng Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shandong Quangang Pharmaceutical
Shanghai Huaxin Biological high-tech
Beijing Yuance Pharmaceutical
Beijing Sihuan Biological Pharmaceutical
Beijing Sanyuan Gene Pharmaceutical
Shenzhen Kexing Biological Engineering
Shanghai Sanwei Biotechnology
Xiamen Tebao Biological Engineering
Chengdu huashen Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical
Segment by Type
50000 U
100000 U
200000 U
500000 U
1 Million U
2 Million U
Segment by Application
Recombinant Interferon
Recombinant Interleukin
Natural Biological Products
Poison Immune
Gene Therapy
Monoclonal Antibody
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Interleukin-2 (IL-2) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Interleukin-2 (IL-2) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Interleukin-2 (IL-2) Market Overview
1.1 Product Overview and Scope of Human Interleukin-2 (IL-2)
1.2 Human Interleukin-2 (IL-2) Segment by Type
1.2.1 Global Human Interleukin-2 (IL-2) Market Value Comparison by Type (2024-2030)
1.2.2 50000 U
1.2.3 100000 U
1.2.4 200000 U
1.2.5 500000 U
1.2.6 1 Million U
1.2.7 2 Million U
1.3 Human Interleukin-2 (IL-2) Segment by Application
1.3.1 Global Human Interleukin-2 (IL-2) Market Value by Application: (2024-2030)
1.3.2 Recombinant Interferon
1.3.3 Recombinant Interleukin
1.3.4 Natural Biological Products
1.3.5 Poison Immune
1.3.6 Gene Therapy
1.3.7 Monoclonal Antibody
1.4 Global Human Interleukin-2 (IL-2) Market Size Estimates and Forecasts
1.4.1 Global Human Interleukin-2 (IL-2) Revenue 2019-2030
1.4.2 Global Human Interleukin-2 (IL-2) Sales 2019-2030
1.4.3 Global Human Interleukin-2 (IL-2) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Interleukin-2 (IL-2) Market Competition by Manufacturers
2.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Interleukin-2 (IL-2) Average Price by Manufacturers (2019-2024)
2.4 Global Human Interleukin-2 (IL-2) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Interleukin-2 (IL-2), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Interleukin-2 (IL-2), Product Type & Application
2.7 Human Interleukin-2 (IL-2) Market Competitive Situation and Trends
2.7.1 Human Interleukin-2 (IL-2) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Interleukin-2 (IL-2) Players Market Share by Revenue
2.7.3 Global Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Interleukin-2 (IL-2) Retrospective Market Scenario by Region
3.1 Global Human Interleukin-2 (IL-2) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Interleukin-2 (IL-2) Global Human Interleukin-2 (IL-2) Sales by Region: 2019-2030
3.2.1 Global Human Interleukin-2 (IL-2) Sales by Region: 2019-2024
3.2.2 Global Human Interleukin-2 (IL-2) Sales by Region: 2025-2030
3.3 Global Human Interleukin-2 (IL-2) Global Human Interleukin-2 (IL-2) Revenue by Region: 2019-2030
3.3.1 Global Human Interleukin-2 (IL-2) Revenue by Region: 2019-2024
3.3.2 Global Human Interleukin-2 (IL-2) Revenue by Region: 2025-2030
3.4 North America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
3.4.1 North America Human Interleukin-2 (IL-2) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Interleukin-2 (IL-2) Sales by Country (2019-2030)
3.4.3 North America Human Interleukin-2 (IL-2) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Interleukin-2 (IL-2) Market Facts & Figures by Country
3.5.1 Europe Human Interleukin-2 (IL-2) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Interleukin-2 (IL-2) Sales by Country (2019-2030)
3.5.3 Europe Human Interleukin-2 (IL-2) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Interleukin-2 (IL-2) Market Facts & Figures by Country
3.6.1 Asia Pacific Human Interleukin-2 (IL-2) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Interleukin-2 (IL-2) Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Interleukin-2 (IL-2) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
3.7.1 Latin America Human Interleukin-2 (IL-2) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Interleukin-2 (IL-2) Sales by Country (2019-2030)
3.7.3 Latin America Human Interleukin-2 (IL-2) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Interleukin-2 (IL-2) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Interleukin-2 (IL-2) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Interleukin-2 (IL-2) Sales by Type (2019-2030)
4.1.1 Global Human Interleukin-2 (IL-2) Sales by Type (2019-2024)
4.1.2 Global Human Interleukin-2 (IL-2) Sales by Type (2025-2030)
4.1.3 Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2019-2030)
4.2 Global Human Interleukin-2 (IL-2) Revenue by Type (2019-2030)
4.2.1 Global Human Interleukin-2 (IL-2) Revenue by Type (2019-2024)
4.2.2 Global Human Interleukin-2 (IL-2) Revenue by Type (2025-2030)
4.2.3 Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2019-2030)
4.3 Global Human Interleukin-2 (IL-2) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Interleukin-2 (IL-2) Sales by Application (2019-2030)
5.1.1 Global Human Interleukin-2 (IL-2) Sales by Application (2019-2024)
5.1.2 Global Human Interleukin-2 (IL-2) Sales by Application (2025-2030)
5.1.3 Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2019-2030)
5.2 Global Human Interleukin-2 (IL-2) Revenue by Application (2019-2030)
5.2.1 Global Human Interleukin-2 (IL-2) Revenue by Application (2019-2024)
5.2.2 Global Human Interleukin-2 (IL-2) Revenue by Application (2025-2030)
5.2.3 Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2019-2030)
5.3 Global Human Interleukin-2 (IL-2) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Human Interleukin-2 (IL-2) Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BMS
6.2.1 BMS Corporation Information
6.2.2 BMS Description and Business Overview
6.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BMS Human Interleukin-2 (IL-2) Product Portfolio
6.2.5 BMS Recent Developments/Updates
6.3 Schering-Plough
6.3.1 Schering-Plough Corporation Information
6.3.2 Schering-Plough Description and Business Overview
6.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Schering-Plough Human Interleukin-2 (IL-2) Product Portfolio
6.3.5 Schering-Plough Recent Developments/Updates
6.4 AbbVie Inc
6.4.1 AbbVie Inc Corporation Information
6.4.2 AbbVie Inc Description and Business Overview
6.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AbbVie Inc Human Interleukin-2 (IL-2) Product Portfolio
6.4.5 AbbVie Inc Recent Developments/Updates
6.5 Alkermes Plc
6.5.1 Alkermes Plc Corporation Information
6.5.2 Alkermes Plc Description and Business Overview
6.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alkermes Plc Human Interleukin-2 (IL-2) Product Portfolio
6.5.5 Alkermes Plc Recent Developments/Updates
6.6 APT Therapeutics
6.6.1 APT Therapeutics Corporation Information
6.6.2 APT Therapeutics Description and Business Overview
6.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 APT Therapeutics Human Interleukin-2 (IL-2) Product Portfolio
6.6.5 APT Therapeutics Recent Developments/Updates
6.7 Mabtech Limited
6.6.1 Mabtech Limited Corporation Information
6.6.2 Mabtech Limited Description and Business Overview
6.6.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mabtech Limited Human Interleukin-2 (IL-2) Product Portfolio
6.7.5 Mabtech Limited Recent Developments/Updates
6.8 Philogen
6.8.1 Philogen Corporation Information
6.8.2 Philogen Description and Business Overview
6.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Philogen Human Interleukin-2 (IL-2) Product Portfolio
6.8.5 Philogen Recent Developments/Updates
6.9 Sinopharm
6.9.1 Sinopharm Corporation Information
6.9.2 Sinopharm Description and Business Overview
6.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sinopharm Human Interleukin-2 (IL-2) Product Portfolio
6.9.5 Sinopharm Recent Developments/Updates
6.10 Jiangsu Jinsili Pharmaceutical
6.10.1 Jiangsu Jinsili Pharmaceutical Corporation Information
6.10.2 Jiangsu Jinsili Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.10.5 Jiangsu Jinsili Pharmaceutical Recent Developments/Updates
6.11 Shenyang Sansheng Pharmaceutical
6.11.1 Shenyang Sansheng Pharmaceutical Corporation Information
6.11.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.11.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.11.5 Shenyang Sansheng Pharmaceutical Recent Developments/Updates
6.12 Beijing Shuanglu Pharmaceutical
6.12.1 Beijing Shuanglu Pharmaceutical Corporation Information
6.12.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.12.5 Beijing Shuanglu Pharmaceutical Recent Developments/Updates
6.13 Shandong Quangang Pharmaceutical
6.13.1 Shandong Quangang Pharmaceutical Corporation Information
6.13.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.13.5 Shandong Quangang Pharmaceutical Recent Developments/Updates
6.14 Shanghai Huaxin Biological high-tech
6.14.1 Shanghai Huaxin Biological high-tech Corporation Information
6.14.2 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Description and Business Overview
6.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Portfolio
6.14.5 Shanghai Huaxin Biological high-tech Recent Developments/Updates
6.15 Beijing Yuance Pharmaceutical
6.15.1 Beijing Yuance Pharmaceutical Corporation Information
6.15.2 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.15.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
6.16 Beijing Sihuan Biological Pharmaceutical
6.16.1 Beijing Sihuan Biological Pharmaceutical Corporation Information
6.16.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.16.5 Beijing Sihuan Biological Pharmaceutical Recent Developments/Updates
6.17 Beijing Sanyuan Gene Pharmaceutical
6.17.1 Beijing Sanyuan Gene Pharmaceutical Corporation Information
6.17.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.17.5 Beijing Sanyuan Gene Pharmaceutical Recent Developments/Updates
6.18 Shenzhen Kexing Biological Engineering
6.18.1 Shenzhen Kexing Biological Engineering Corporation Information
6.18.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Description and Business Overview
6.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Portfolio
6.18.5 Shenzhen Kexing Biological Engineering Recent Developments/Updates
6.19 Shanghai Sanwei Biotechnology
6.19.1 Shanghai Sanwei Biotechnology Corporation Information
6.19.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Description and Business Overview
6.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Portfolio
6.19.5 Shanghai Sanwei Biotechnology Recent Developments/Updates
6.20 Xiamen Tebao Biological Engineering
6.20.1 Xiamen Tebao Biological Engineering Corporation Information
6.20.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Description and Business Overview
6.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Portfolio
6.20.5 Xiamen Tebao Biological Engineering Recent Developments/Updates
6.21 Chengdu huashen Biotechnology
6.21.1 Chengdu huashen Biotechnology Corporation Information
6.21.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Description and Business Overview
6.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Portfolio
6.21.5 Chengdu huashen Biotechnology Recent Developments/Updates
6.22 Shanghai Pharma Group
6.22.1 Shanghai Pharma Group Corporation Information
6.22.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Description and Business Overview
6.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Portfolio
6.22.5 Shanghai Pharma Group Recent Developments/Updates
6.23 Guangdong Xinghao Pharmaceutical
6.23.1 Guangdong Xinghao Pharmaceutical Corporation Information
6.23.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
6.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolio
6.23.5 Guangdong Xinghao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Interleukin-2 (IL-2) Industry Chain Analysis
7.2 Human Interleukin-2 (IL-2) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Interleukin-2 (IL-2) Production Mode & Process
7.4 Human Interleukin-2 (IL-2) Sales and Marketing
7.4.1 Human Interleukin-2 (IL-2) Sales Channels
7.4.2 Human Interleukin-2 (IL-2) Distributors
7.5 Human Interleukin-2 (IL-2) Customers
8 Human Interleukin-2 (IL-2) Market Dynamics
8.1 Human Interleukin-2 (IL-2) Industry Trends
8.2 Human Interleukin-2 (IL-2) Market Drivers
8.3 Human Interleukin-2 (IL-2) Market Challenges
8.4 Human Interleukin-2 (IL-2) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Interleukin-2 (IL-2) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Interleukin-2 (IL-2) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Interleukin-2 (IL-2) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Interleukin-2 (IL-2) Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Human Interleukin-2 (IL-2) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Interleukin-2 (IL-2) Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Interleukin-2 (IL-2), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Interleukin-2 (IL-2), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Interleukin-2 (IL-2), Product Type & Application
Table 12. Global Key Manufacturers of Human Interleukin-2 (IL-2), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Interleukin-2 (IL-2) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Interleukin-2 (IL-2) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Interleukin-2 (IL-2) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Interleukin-2 (IL-2) Sales by Region (2019-2024) & (KG)
Table 18. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2019-2024)
Table 19. Global Human Interleukin-2 (IL-2) Sales by Region (2025-2030) & (KG)
Table 20. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2025-2030)
Table 21. Global Human Interleukin-2 (IL-2) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region (2019-2024)
Table 23. Global Human Interleukin-2 (IL-2) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region (2025-2030)
Table 25. North America Human Interleukin-2 (IL-2) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Interleukin-2 (IL-2) Sales by Country (2019-2024) & (KG)
Table 27. North America Human Interleukin-2 (IL-2) Sales by Country (2025-2030) & (KG)
Table 28. North America Human Interleukin-2 (IL-2) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Interleukin-2 (IL-2) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Interleukin-2 (IL-2) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Interleukin-2 (IL-2) Sales by Country (2019-2024) & (KG)
Table 32. Europe Human Interleukin-2 (IL-2) Sales by Country (2025-2030) & (KG)
Table 33. Europe Human Interleukin-2 (IL-2) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Interleukin-2 (IL-2) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Interleukin-2 (IL-2) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Interleukin-2 (IL-2) Sales by Country (2019-2024) & (KG)
Table 42. Latin America Human Interleukin-2 (IL-2) Sales by Country (2025-2030) & (KG)
Table 43. Latin America Human Interleukin-2 (IL-2) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Interleukin-2 (IL-2) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Interleukin-2 (IL-2) Sales (KG) by Type (2019-2024)
Table 51. Global Human Interleukin-2 (IL-2) Sales (KG) by Type (2025-2030)
Table 52. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2019-2024)
Table 53. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2025-2030)
Table 54. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2019-2024)
Table 57. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2025-2030)
Table 58. Global Human Interleukin-2 (IL-2) Price (US$/G) by Type (2019-2024)
Table 59. Global Human Interleukin-2 (IL-2) Price (US$/G) by Type (2025-2030)
Table 60. Global Human Interleukin-2 (IL-2) Sales (KG) by Application (2019-2024)
Table 61. Global Human Interleukin-2 (IL-2) Sales (KG) by Application (2025-2030)
Table 62. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2019-2024)
Table 63. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2025-2030)
Table 64. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2019-2024)
Table 67. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2025-2030)
Table 68. Global Human Interleukin-2 (IL-2) Price (US$/G) by Application (2019-2024)
Table 69. Global Human Interleukin-2 (IL-2) Price (US$/G) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Roche Human Interleukin-2 (IL-2) Product
Table 74. Roche Recent Developments/Updates
Table 75. BMS Corporation Information
Table 76. BMS Description and Business Overview
Table 77. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. BMS Human Interleukin-2 (IL-2) Product
Table 79. BMS Recent Developments/Updates
Table 80. Schering-Plough Corporation Information
Table 81. Schering-Plough Description and Business Overview
Table 82. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Schering-Plough Human Interleukin-2 (IL-2) Product
Table 84. Schering-Plough Recent Developments/Updates
Table 85. AbbVie Inc Corporation Information
Table 86. AbbVie Inc Description and Business Overview
Table 87. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. AbbVie Inc Human Interleukin-2 (IL-2) Product
Table 89. AbbVie Inc Recent Developments/Updates
Table 90. Alkermes Plc Corporation Information
Table 91. Alkermes Plc Description and Business Overview
Table 92. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Alkermes Plc Human Interleukin-2 (IL-2) Product
Table 94. Alkermes Plc Recent Developments/Updates
Table 95. APT Therapeutics Corporation Information
Table 96. APT Therapeutics Description and Business Overview
Table 97. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. APT Therapeutics Human Interleukin-2 (IL-2) Product
Table 99. APT Therapeutics Recent Developments/Updates
Table 100. Mabtech Limited Corporation Information
Table 101. Mabtech Limited Description and Business Overview
Table 102. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Mabtech Limited Human Interleukin-2 (IL-2) Product
Table 104. Mabtech Limited Recent Developments/Updates
Table 105. Philogen Corporation Information
Table 106. Philogen Description and Business Overview
Table 107. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Philogen Human Interleukin-2 (IL-2) Product
Table 109. Philogen Recent Developments/Updates
Table 110. Sinopharm Corporation Information
Table 111. Sinopharm Description and Business Overview
Table 112. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Sinopharm Human Interleukin-2 (IL-2) Product
Table 114. Sinopharm Recent Developments/Updates
Table 115. Jiangsu Jinsili Pharmaceutical Corporation Information
Table 116. Jiangsu Jinsili Pharmaceutical Description and Business Overview
Table 117. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 119. Jiangsu Jinsili Pharmaceutical Recent Developments/Updates
Table 120. Shenyang Sansheng Pharmaceutical Corporation Information
Table 121. Shenyang Sansheng Pharmaceutical Description and Business Overview
Table 122. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 124. Shenyang Sansheng Pharmaceutical Recent Developments/Updates
Table 125. Beijing Shuanglu Pharmaceutical Corporation Information
Table 126. Beijing Shuanglu Pharmaceutical Description and Business Overview
Table 127. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 129. Beijing Shuanglu Pharmaceutical Recent Developments/Updates
Table 130. Shandong Quangang Pharmaceutical Corporation Information
Table 131. Shandong Quangang Pharmaceutical Description and Business Overview
Table 132. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 134. Shandong Quangang Pharmaceutical Recent Developments/Updates
Table 135. Shanghai Huaxin Biological high-tech Corporation Information
Table 136. Shanghai Huaxin Biological high-tech Description and Business Overview
Table 137. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product
Table 139. Shanghai Huaxin Biological high-tech Recent Developments/Updates
Table 140. Beijing Yuance Pharmaceutical Corporation Information
Table 141. Beijing Yuance Pharmaceutical Description and Business Overview
Table 142. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 144. Beijing Yuance Pharmaceutical Recent Developments/Updates
Table 145. Beijing Sihuan Biological Pharmaceutical Corporation Information
Table 146. Beijing Sihuan Biological Pharmaceutical Description and Business Overview
Table 147. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 149. Beijing Sihuan Biological Pharmaceutical Recent Developments/Updates
Table 150. Beijing Sanyuan Gene Pharmaceutical Corporation Information
Table 151. Beijing Sanyuan Gene Pharmaceutical Description and Business Overview
Table 152. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 154. Beijing Sanyuan Gene Pharmaceutical Recent Developments/Updates
Table 155. Shenzhen Kexing Biological Engineering Corporation Information
Table 156. Shenzhen Kexing Biological Engineering Description and Business Overview
Table 157. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product
Table 159. Shenzhen Kexing Biological Engineering Recent Developments/Updates
Table 160. Shanghai Sanwei Biotechnology Corporation Information
Table 161. Shanghai Sanwei Biotechnology Description and Business Overview
Table 162. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product
Table 164. Shanghai Sanwei Biotechnology Recent Developments/Updates
Table 165. Xiamen Tebao Biological Engineering Corporation Information
Table 166. Xiamen Tebao Biological Engineering Description and Business Overview
Table 167. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 168. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product
Table 169. Xiamen Tebao Biological Engineering Recent Developments/Updates
Table 170. Chengdu huashen Biotechnology Corporation Information
Table 171. Chengdu huashen Biotechnology Description and Business Overview
Table 172. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 173. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product
Table 174. Chengdu huashen Biotechnology Recent Developments/Updates
Table 175. Shanghai Pharma Group Corporation Information
Table 176. Shanghai Pharma Group Description and Business Overview
Table 177. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 178. Shanghai Pharma Group Human Interleukin-2 (IL-2) Product
Table 179. Shanghai Pharma Group Recent Developments/Updates
Table 180. Guangdong Xinghao Pharmaceutical Corporation Information
Table 181. Guangdong Xinghao Pharmaceutical Description and Business Overview
Table 182. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 183. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product
Table 184. Guangdong Xinghao Pharmaceutical Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Human Interleukin-2 (IL-2) Distributors List
Table 188. Human Interleukin-2 (IL-2) Customers List
Table 189. Human Interleukin-2 (IL-2) Market Trends
Table 190. Human Interleukin-2 (IL-2) Market Drivers
Table 191. Human Interleukin-2 (IL-2) Market Challenges
Table 192. Human Interleukin-2 (IL-2) Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Interleukin-2 (IL-2)
Figure 2. Global Human Interleukin-2 (IL-2) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Interleukin-2 (IL-2) Market Share by Type in 2023 & 2030
Figure 4. 50000 U Product Picture
Figure 5. 100000 U Product Picture
Figure 6. 200000 U Product Picture
Figure 7. 500000 U Product Picture
Figure 8. 1 Million U Product Picture
Figure 9. 2 Million U Product Picture
Figure 10. Global Human Interleukin-2 (IL-2) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Human Interleukin-2 (IL-2) Market Share by Application in 2023 & 2030
Figure 12. Recombinant Interferon
Figure 13. Recombinant Interleukin
Figure 14. Natural Biological Products
Figure 15. Poison Immune
Figure 16. Gene Therapy
Figure 17. Monoclonal Antibody
Figure 18. Global Human Interleukin-2 (IL-2) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Human Interleukin-2 (IL-2) Market Size (2019-2030) & (US$ Million)
Figure 20. Global Human Interleukin-2 (IL-2) Sales (2019-2030) & (KG)
Figure 21. Global Human Interleukin-2 (IL-2) Average Price (US$/G) & (2019-2030)
Figure 22. Human Interleukin-2 (IL-2) Report Years Considered
Figure 23. Human Interleukin-2 (IL-2) Sales Share by Manufacturers in 2023
Figure 24. Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers in 2023
Figure 25. The Global 5 and 10 Largest Human Interleukin-2 (IL-2) Players: Market Share by Revenue in 2023
Figure 26. Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 27. Global Human Interleukin-2 (IL-2) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 28. North America Human Interleukin-2 (IL-2) Sales Market Share by Country (2019-2030)
Figure 29. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2019-2030)
Figure 30. U.S. Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Canada Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2019-2030)
Figure 33. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2019-2030)
Figure 34. Germany Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. France Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. U.K. Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Italy Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Russia Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region (2019-2030)
Figure 40. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region (2019-2030)
Figure 41. China Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Japan Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. South Korea Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. India Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Taiwan Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Indonesia Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Thailand Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Malaysia Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Philippines Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country (2019-2030)
Figure 52. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2019-2030)
Figure 53. Mexico Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Brazil Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Argentina Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2019-2030)
Figure 58. Turkey Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE Human Interleukin-2 (IL-2) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of Human Interleukin-2 (IL-2) by Type (2019-2030)
Figure 62. Global Revenue Market Share of Human Interleukin-2 (IL-2) by Type (2019-2030)
Figure 63. Global Human Interleukin-2 (IL-2) Price (US$/G) by Type (2019-2030)
Figure 64. Global Sales Market Share of Human Interleukin-2 (IL-2) by Application (2019-2030)
Figure 65. Global Revenue Market Share of Human Interleukin-2 (IL-2) by Application (2019-2030)
Figure 66. Global Human Interleukin-2 (IL-2) Price (US$/G) by Application (2019-2030)
Figure 67. Human Interleukin-2 (IL-2) Value Chain
Figure 68. Human Interleukin-2 (IL-2) Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
